Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico
Salvatore Vaccarella
International Agency for Research on Cancer, Lyon, France
Search for more papers by this authorCorresponding Author
Eduardo Lazcano-Ponce
Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico
Fax: +52-777-311-11-48.
Centro de Investigaciones en Salud Poblacional, Instituto Nacional de Salud Pública, Av. Universidad 655, Col. Sta Maria, Ahuacatitlan, C.P. 62508 Cuernavaca, Morelos, MexicoSearch for more papers by this authorJosé Antonio Castro-Garduño
Dirección General de Equidad y Género en Salud, Dirección de Salud Reproductiva, Mexico City, Mexico
Search for more papers by this authorAurelio Cruz-Valdez
Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico
Search for more papers by this authorVicente Díaz
Fundación Mexicana para la Planeación Familiar, Mexico City, Mexico
Search for more papers by this authorRafaela Schiavon
Dirección General de Equidad y Género en Salud, Dirección de Salud Reproductiva, Mexico City, Mexico
Search for more papers by this authorPilar Hernández
Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico
Search for more papers by this authorMauricio Hernández-Avila
Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico
Search for more papers by this authorSilvia Franceschi
International Agency for Research on Cancer, Lyon, France
Search for more papers by this authorSalvatore Vaccarella
International Agency for Research on Cancer, Lyon, France
Search for more papers by this authorCorresponding Author
Eduardo Lazcano-Ponce
Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico
Fax: +52-777-311-11-48.
Centro de Investigaciones en Salud Poblacional, Instituto Nacional de Salud Pública, Av. Universidad 655, Col. Sta Maria, Ahuacatitlan, C.P. 62508 Cuernavaca, Morelos, MexicoSearch for more papers by this authorJosé Antonio Castro-Garduño
Dirección General de Equidad y Género en Salud, Dirección de Salud Reproductiva, Mexico City, Mexico
Search for more papers by this authorAurelio Cruz-Valdez
Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico
Search for more papers by this authorVicente Díaz
Fundación Mexicana para la Planeación Familiar, Mexico City, Mexico
Search for more papers by this authorRafaela Schiavon
Dirección General de Equidad y Género en Salud, Dirección de Salud Reproductiva, Mexico City, Mexico
Search for more papers by this authorPilar Hernández
Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico
Search for more papers by this authorMauricio Hernández-Avila
Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico
Search for more papers by this authorSilvia Franceschi
International Agency for Research on Cancer, Lyon, France
Search for more papers by this authorAbstract
Large studies of genital human papillomavirus (HPV) infection in men are few and mainly include high-risk groups. We interviewed 779 men who requested a vasectomy in 27 public clinics in 14 states of Mexico. Exfoliated cells were obtained from the scrotum, the shaft of the penis, the top of the penis including the coronal sulcus, the glans and the opening of the meatus. HPV testing was performed using biotinylated L1 consensus primers and reverse line blot. Unconditional logistic regression was used to estimate odds ratios (ORs) of being HPV-positive and corresponding 95% confidence intervals (CIs). The prevalence of any type of HPV was 8.7%. HPV positivity was highest among men below age 25 (13.6%), and lowest among men aged 40 years or older (6.0%). The most commonly found HPV types were, in decreasing order, HPV59, 51, 6, 16 and 58. Lifetime number of sexual partners was associated with HPV positivity (OR for ≥4 vs. 1 partner = 3.7, 95% CI: 2.0–6.8), mainly on account of the strong association with number of occasional and sex-worker partners. Condom use with both regular (OR = 0.4, 95% CI: 0.1–1.0) and sex-worker (OR = 0.1, 95% CI: 0.0–0.3) partners and circumcision (OR = 0.2, 95% CI: 0.1–0.4) were inversely associated with HPV positivity. HPV prevalence in Mexican men was similar to the prevalence found in Mexican women of the same age groups. The association between HPV positivity and lifetime number of sexual partners in the present low-risk male population is one of the strongest ever reported in studies in men. Condom use and circumcision were associated with a strong reduction in HPV prevalence. © 2006 Wiley-Liss, Inc.
References
- 1
Walboomers JM,
Jacobs MV,
Manos MM,
Bosch FX,
Kummer JA,
Shah KV,
Snijders PJF,
Peto J,
Meijer CJLM,
Muñoz N.
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
J Pathol
1999;
189:
12–19.
10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- 2 Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJF, Vaccarella S, Anh PTH, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991–8.
- 3 von Krogh G. Management of anogenital warts (condylomata acuminata). Eur J Dermatol 2001; 11: 598–603.
- 4 Bleeker MC, Hogewoning CJ, Berkhof J, Voorhorst FJ, Hesselink AT, van Diemen PM, van den Brule AJ, Snijders PJF, Meijer CJLM. Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 2005; 41: 612–20.
- 5 Baken LA, Koutsky LA, Kuypers J, Kosorok MR, Lee SK, Kiviat NB, Holmes KK. Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance. J Infect Dis 1995; 171: 429–32.
- 6 Bosch FX, Castellsagué X, Muñoz N, de Sanjosé S, Ghaffari AM, Gonzalez LC, Gili M, Izarzugaza I, Viladiu P, Navarro C, Vergara A, Ascunce N, et al. Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996; 88: 1060–7.
- 7 Castellsagué X, Ghaffari A, Daniel RW, Bosch FX, Muñoz N, Shah KV. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 1997; 176: 353–61.
- 8 Franceschi S, Castellsagué X, Dal Maso L, Smith JS, Plummer M, Ngelangel C, Chichareon S, Eluf-Neto J, Shah KV, Snijders PJF, Meijer CJLM, Bosch FX, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 2002; 86: 705–11.
- 9 Svare EI, Kjaer SK, Worm AM, Osterlind A, Meijer CJLM, van den Brule AJ. Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect 2002; 78: 215–18.
- 10 Castellsagué X, Bosch FX, Muñoz N, Meijer CJLM, Shah KV, de Sanjosé S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, Herrero R, Moreno V, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002; 346: 1105–12.
- 11 IARC. Human papillomavirus. Monographs on the evaluation of carcinogenic risks to humans, vol. 64. Lyon: International Agency for Research on Cancer, 1995.
- 12 Lazcano-Ponce E, Herrero R, Muñoz N, Hernandez-Avila M, Salmeron J, Leyva A, Meijer CJLM, Walboomers JM. High prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples. Sex Transm Dis 2001; 28: 277–80.
- 13 Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Kornegay JR, Hallum JA, Redmond SA, Giuliano AR. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis 2003; 187: 1064–70.
- 14 Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Giuliano AR. Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis 2004; 31: 601–7.
- 15 Hippelainen M, Syrjanen S, Hippelainen M, Koskela H, Pulkkinen J, Saarikoski S, Syrjanen K. Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis 1993; 20: 321–8.
- 16 Kjaer SK, Munk C, Winther JF, Jorgensen HO, Meijer CJLM, van den Brule AJ. Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 2005; 14: 1528–33.
- 17 Lajous M, Mueller N, Cruz-Valdez A, Aguilar LV, Franceschi S, Hernandez-Avila M, Lazcano-Ponce E. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev 2005; 14: 1710–16.
- 18 Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998; 36: 3020–7.
- 19 Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 357–61.
- 20 Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518–27.
- 21 DM Parkin, SL Whelan, J Ferlay, DB Thomas, L Teppo, eds. Cancer incidence in five continents, vol. VIII. Lyon: IARC, 2002. IARC Scientific Publications No: 155.
- 22
Lazcano-Ponce E,
Herrero R,
Muñoz N,
Cruz A,
Shah KV,
Alonso P,
Hernandez P,
Salmeron J,
Hernandez M.
Epidemiology of HPV infection among Mexican women with normal cervical cytology.
Int J Cancer
2001;
91:
412–20.
10.1002/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- 23 Juarez-Figueroa LA, Wheeler CM, Uribe-Salas FJ, Conde-Glez CJ, Zampilpa-Mejia LG, Garcia-Cisneros S, Hernandez-Avila M. Human papillomavirus: a highly prevalent sexually transmitted disease agent among female sex workers from Mexico City. Sex Transm Dis 2001; 28: 125–30.
- 24 Muñoz N, Castellsagué X, Bosch FX, Tafur L, de Sanjosé S, Aristizabal N, Ghaffari AM, Shah KV. Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease. J Natl Cancer Inst 1996; 88: 1068–75.
- 25 Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002; 29: 725–35.
- 26 Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005; 191: 1796–807.
- 27 Vaccarella S, Franceschi S, Herrero R, Muñoz N, Snijders PJF, Clifford GM, Smith JS, Lazcano-Ponce E, Sukvirach S, Shin HR, de Sanjosé S, Molano M et al. Sexual behaviour, condom use and HPV: pooled analysis of the International Agency for Research on Cancer HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006; 15: 326–33.
- 28 Bleeker MC, Berkhof J, Hogewoning CJ, Voorhorst FJ, van den Brule AJ, Starink TM, Snijders PJF, Meijer CJLM. HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions. Br J Cancer 2005; 92: 1388–92.
- 29 Coutlee F, de Ladurantaye M, Tremblay C, Vincelette J, Labrecque L, Roger M. An important proportion of genital samples submitted for Chlamydia trachomatis detection by PCR contain small amounts of cellular DNA as measured by β-globin gene amplification. J Clin Microbiol 2000; 38: 2512–15.
- 30 Aguilar LV, Lazcano-Ponce E, Vaccarella S, Cruz A, Hernández P, Smith JS, Muñoz N, Kornegay JR, Hernández-Avila M, Franceschi S. Human papillomavirus in men: comparison of different genital sites. Sex Transm Infect 2006; 82: 31–3.
- 31 Jezowski TW, Alarcón F, Juárez C, Estrada A, Gómez F. A successful national program for expanding vasectomy services: the experience of the Instituto Mexicano del Seguro Social. AVSC Working Paper No. 8. June 1995. Available at: www.engenderhealth.org/pubs/workpap/wp8/wp_8.html